Anthera Pharmaceuticals, Inc.
ANTH · OTC
12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|---|
| Market Cap | $18,398 | $26,800 | $165,329 | $34,406 |
| - Cash | $2,196 | $20,843 | $46,951 | $2,639 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $16,202 | $5,957 | $118,378 | $31,767 |
| Revenue | $0 | $145 | $3,185 | $0 |
| % Growth | -100% | -95.4% | – | – |
| Gross Profit | -$281 | $99 | $3,154 | -$22 |
| % Margin | – | 68.1% | 99% | – |
| EBITDA | -$26,593 | -$56,911 | -$34,958 | -$28,211 |
| % Margin | – | -39,249% | -1,097.6% | – |
| Net Income | -$16,935 | -$53,603 | -$34,912 | -$30,309 |
| % Margin | – | -36,967.6% | -1,096.1% | – |
| EPS Diluted | -1.65 | -10.38 | -7.84 | -11.13 |
| % Growth | 84.1% | -32.4% | 29.6% | – |
| Operating Cash Flow | -$36,900 | -$48,919 | -$30,907 | -$25,601 |
| Capital Expenditures | $0 | -$766 | -$80 | $0 |
| Free Cash Flow | -$36,900 | -$49,685 | -$30,987 | -$25,601 |